CrossrefInfokarte
Very Early Biologic Therapy within Six Months of Crohn’s Disease Diagnosis Improves One-Year Steroid-Free Clinical Remission: A Retrospective Cohort Study
Digestion · 2026-01-09 · 1-10
DOI: 10.1159/000550394 ↗Abstract
Introduction: Early use of biologics improves outcomes for Crohn’s disease (CD). Evidence now indicates that initiating therapy within 6 months of diagnosis – the “very early” window – may yield additional benefits over the traditional ≤2-year target. We therefore compared 1-year outcomes after very early (
EUVIMED